| Field | Specification |
|---|---|
| Applications | |
| Sterility | Negative for bacteria, yeast, fungi and mycoplasma. |
| Cell type | |
| Form | Liquid |
| Storage | |
| Shipping | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Osteogenic Differentiation Medium is designed to efficiently induce adipose-derived stem cells differentiation into osteoblasts. This medium is fully supplemented and containing 10% fetal bovine serum. This medium is sterile filtered and is ready for use.
Osteogenic Differentiation Medium is a sterile-filtered, ready-to-use liquid medium from iXCells Biotechnologies for the differentiation of Adipose-Derived Stem Cells in vitro. Each lot is screened for bacteria, yeast, fungi and mycoplasma before release.
Specifications
| Catalog No. | MD-0006 |
|---|---|
| Package Size | 500 mL |
| Form | Liquid |
| Sterility | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Avoid exposure to light. Suitable for 6 months at 4 o C. |
| Shipping | Dry ice |
QC & Validation
Lot-release testing
Each lot was tested for the ability to induce differentiation of adipose-derived stem cells into osteoblasts with accumulation of extracellular calcium deposit within 2~3 weeks.
Storage & Handling
Citing Publication
Kilinc MO, Santidrian A, Minev I, Toth R, Draganov D, Nguyen D, … Szalay AA. (2018). The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clinical and Translational Medicine, 7(1). 10.1186/s40169-018-0183-8
Osteogenic Differentiation Medium is for research use only. It is not approved for human or animal use, or for application in in vitro diagnostic procedures.
Customization & Add-ons: Need this medium in a format that fits your protocol—or a formulation we don’t list? We can help you source the best match or support custom culture media for diverse research needs, including basal medium and complete medium formats, serum options (defined FBS lot, low-serum, serum-free or xeno-free), antibiotic preferences (antibiotic-free, Penicillin-Streptomycin or Antibiotic-Antimycotic), phenol red–free formulations, supplement and growth-factor adjustments (concentration changes, separate supplement packs, custom component kits), fill volume and packaging (small aliquots through bulk volumes), and lot reservation and repeat-order continuity for longitudinal studies (project dependent). We can also help you pair a medium with matched primary cells, coating reagents and dissociation solutions. Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Kilinc MO, Santidrian A, Minev I, Toth R, Draganov D, Nguyen D, … Szalay AA. (2018). The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy. Clinical and Translational Medicine, 7(1). 10.1186/s40169-018-0183-8